The qk v mutation is a one megabase deletion resulting in abnormal expression of the qkI gene. qk v mice exhibit hypomyelination of the central nervous system and display rapid tremors and seizures as adults. The qkI locus on 6q26-27 has also been implicated as a candidate tumor suppressor gene as the qkI locus maps to a region of genetic instability in Glioblastoma Multiforme (GBM), an aggressive brain tumor of astrocytic lineage. As GBM frequently harbors mutations affecting p53, we crossbred qk v and p53 mutant mice to examine whether qk v mice on a p53 2/2 background have an increased incidence of GBM. qk v/v ; p53 2/2 mice had a reduced survival rate compared to p53 2/2 littermates, and the cause of death of the majority of the mice remains unknown. In addition, immunohistochemistry revealed Purkinje cell degeneration in the cerebellum. These results suggest that p53 and qkI are genetically linked for neuronal maintenance and survival.
T he study of neurological diseases has been greatly advanced with the use of mouse models. In particular, spontaneously occurring mutant mice have played an important role in identifying key components required for proper myelination. One such mouse, the autosomal recessive qk v mutant, was first described in 1964 by Sidman and colleagues. The qk v/v mouse exhibited severe hypomyelination of the central and peripheral nervous system and severe hindlimb shaking 1 . The mutation responsible for the qk v/v phenotype was later identified as a one megabase deletion that results in loss of parkin (park2) and parkin co-regulated (pacrg) function, whereas qkI expression becomes abnormally expressed [2] [3] [4] . In qk v/v mutants, qkI-6/7 expression is preferentially lost in myelin producing cells of the central and peripheral nervous systems, while for the most part expression remains unaffected in all other cell types 3 . The qkI gene encodes for the alternatively spliced KH domain RNA binding proteins QKI-5, -6, and -7 5 . QKI has been shown to regulate important mRNA targets involved in myelination and oligodendrocyte differentiation [6] [7] [8] [9] [10] [11] . QKI is implicated in myelinogenesis by stabilizing myelin basic protein (MBP) mRNA 6, 12 , regulating the alternative splicing pattern of myelin associated glycoprotein (MAG) 10, 13 , and oligodendrocyte differentiation and Schwann cell differentiation 7, 14 . The overexpression of QKI-6 in qk v mutants has been shown to rescue the myelination defect 15 . In addition to myelination defects, qk v mice also exhibit ciliopathies including male sterility and mild hydrocephalus [16] [17] . Cilia lining the ventricles of the brain are responsible for proper circulation of cerebral spinal fluid (CSF). Ciliogenesis is normal in qk v mice, however the cilia are functionally impaired leading to decreased CSF flow and hydrocephalus 16 . Hydrocephalus in qk v mice becomes fatal on a patched1 (ptch1) heterozygous background 18 . The long arm of chromosome 6 is known to harbor a common fragile site that is frequently lost or mutated in a variety of cancers [19] [20] . The breakpoint includes several genes, one of which has been identified as the qkI gene [21] [22] . Chromosomal aberrations at 6q26-27 are common in Glioblastoma Multiforme (GBM) 21 . In addition to mapping to a region of genomic instability, expression of qkI mRNA transcripts have been shown to be altered specifically in human gliomas compared to other brain cancers 23 . Thus, it has been proposed that QKI may function as a tumor suppressor and play a role in GBM progression. Evidence for a suppressor role was shown for the C. elegans GLD-1, a QKI homolog 24 . The GLD-1 C. elegans homolog of QKI is known to associate with the p53 cep-1 mRNA, influencing its activity 25 . In addition, QKI was discovered to be down-regulated in colorectal cancers 26 . QKI over-expression in the colon epithelium resulted in increased levels of p27 kip1 as well as an increase in membrane bound b-catenin, an indicator of gastric cell differentiation 26 . These observations along with our data that QKI-6/-7 cause cell cycle arrest 7 , a property often observed for tumor suppressors, suggest that the absence of QKI proteins may promote tumorigenesis.
Loss of heterozygosity and mutations of the p53 gene is commonly associated with a variety of cancers in multiple organ sites 27 . Individuals with the Li Fraumeni syndrome, in part caused by mutations in the p53 gene, suffer from early onset of many different types of cancer 28 . Mutations abrogating p53 function and allelic loss of chromosome 17p were among the first genetic lesions identified in GBM 29 . p53 lesions are present in all grades of astrocytoma at an average of 30% 30 , suggesting that the inactivation of p53 is an early event in gliomagenesis. p53 1/2 and p53 2/2 mice have been found to develop a broad spectrum of tumors, including lymphomas, osteosarcomas, and fibroscarcomas 31 . p53
1/2 and p53 2/2 mice have been used as a background strain to breed with other mutant strains to produce entirely novel tumor spectrums that were not found in mice with a mutation in p53 alone 32 . Although p53 1/2 mice showed no incidence of any brain malignancy 31, 33 , nf1 2/2 mice also displayed neurological defects including Purkinje neuron degeneration.
Results
The qk v/v mice contain a recessive autosomal mutation of ,1.1 Mb on chromosome 17 affecting the expression of quaking (qkI), parkincoregulated gene (pacrg) and parkin (park2) 4 . The mutation results in aberrant expression of alternatively spliced qkI transcripts, leading to the dysmyelination defects observed in the qk v/v mice 4 . Deletion of the pacrg gene in qk v mice causes ciliopathies including hydrocephalus 16 and male sterility 35 . To examine whether the p53 pathway genetically interacts with the pacrg-parkin-qkI locus in the regulation of the phenotypes of the qk v/v mice, we crossbred the qk v/v mice with p53 null mice. We initially assessed the myelin sheath of resulting qk v/v ; p53 2/2 progeny. Post-natal day 30 (P30) coronal sections of the corpus callosum were stained with an antibody specific to myelin basic protein (MBP). As expected, qk v/v mice showed reduced thickness of the corpus callosum (98.8 6 16.4 mm) compared to wild-type (wt) (172.
2/2 mice did not show an increased severity of hypomyelination compared to qk v/v mice (86.9 6 8.89 mm, Figure 1 ), and corpus callosum thickness was not found to be statistically different between the mice (p 5 0.287). Although corpus callosum thickness was reduced in mice with the qk v mutation, sparse high intensity MBP staining was observed along the myelin tracts. These MBP-positive ''blebs'' have previously been observed in spinal cord white matter of qk v/v mice, corresponding to redundant loops of uncompacted myelin 36 . These results suggest that p53 does not cooperate with qkI in the regulation of myelin formation in vivo. The loss of both wt p53 alleles did not affect the onset of hindlimb shaking in mice pups, since both qk
1/2 mice and qk v/v mice displayed tremors by P14 (data not shown). Common husbandry procedures and animal handling are sources of acute stress and elicit tonic clonic seizures in qk v mice [37] [38] [39] . background. Brains were frozen over acetone-dry ice and cryostat sectioned at a thickness of 10 mm. Coronal sections of age and sex-matched mouse cortexes were stained with anti-MBP antibody. Scale bar represents 100 mm. ; p53 2/2 P14 mice, suggesting that Purkinje cell loss was not due to failure in neuronal migration at earlier stages of development ( Figure 2B ). These results suggest that the Purkinje cell defects observed in qk v/v ; p53 2/2 mice were not due to impaired development, but cell body and dendrite degeneration and defects in neuronal maintenance and survival. Indeed, qkI has been shown play a role in apoptosis in 3T3 mouse fibroblasts, HeLa cells, and primary rat oligodendrocytes [41] [42] . p53
1/2 mice develop primarily sarcomas, with an incidence of 28% over 17 months. p53 2/2 mice have a much accelerated rate of tumorigenesis, with the majority of mice succumbing to lymphomas by six months of age 31 . ; p53 2/2 mice we generated developed primarily sarcomas and lymphomas, with no occurrence ; p53 2/2 mice (142 days, n 5 18) and p53 2/2 mice (172 days, n 5 11) according to the log rank/Mantel Cox test (p 5 0.0135 and p 5 0.0443, respectively). The loss of survival was measured by mice that were found dead or that had to be sacrificed due to illness according to the guidelines of the Canadian Animal Care Committee. (B) Low-power magnification showing macroscopic appearance of medulloblastoma occurring in the cerebellum, with an arrow denoting the tumor area. Higher magnification of medulloblastoma, demonstrating the invasion of the molecular layer by the over proliferation of granular like tumor cells. Section was stained with H&E. Immunohistochemistry performed on the medulloblastoma reveals tumor reactivity to GFAP, NFH, and CD31, specific markers for different cell lineages. ; p53 2/2 mouse showed increased vascularization of the cerebellum and abnormal gross cerebellar architecture. Further histological analysis of cerebellar sections revealed granule cell layer invasion of the surrounding parenchyma, consistent with medulloblastoma ( Figure 3B ). Cytological analysis confirmed the presence of medulloblastoma, as tumor cell nuclei were densely packed and polygonal in shape. Tumor cells were also found to express markers of astrocytic (GFAP), neuronal (NFH) and vascular (CD31) lineage (Fig. 3B) . Cells expressing markers of multiple lineages indicate cells of a stem cell precursor nature, consistent with primitive neuroectodermal tumors such as medulloblastoma. Medulloblastoma has not previously been observed to occur spontaneously in either p53 2/2 or qk v/v mice 1, 31 . One study identified only one instance of a brain malignancy out of a cohort of p53 1/2 mice (n 5 40), whereas another study did not observe any tumors of the nervous system in a cohort of p53 2/2 mice (n 5 35) or p53 1/2 (n 5 96) mice 31, 33 . The one p53 1/2 brain tumor identified was an ependymoma, a tumor originating from the walls of the ventricular system 43 . p53 mutations contribute to approximately 10% of human medulloblastoma cases 44 ; in addition, many mouse models of medulloblastoma have been developed by the combination of a specific tumor suppressor mutation and the loss of p53
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. Although qkI has been mapped to the common fragile site 6q25-26 in GBM, loss of 6q25-26 in medulloblastoma is rare 45 , suggesting that somatic qkI mutations in clinical medulloblastoma do not confer any specific tumorigenetic advantage. QKI has been shown to be expressed in post-natal neural progenitor cells of the SVZ 46 , suggesting that QKI may also be expressed in other populations of multi-potent precursor cells including the rostral rhombic lip progenitor cells that give rise to granule neuronal precursor cells. It has not been determined if the qk v mutation affects QKI expression in neural progenitor cells including granule neuronal precursor cells, therefore it remains a possibility that the loss of qkI-6/7 in the absence of p53 could provide sufficient oncogenic stress to induce transformation.
Discussion
Our study indicates that qk v/v ; p53 2/2 mice do not have decreased corpus callosum thickness or MBP-staining compared to qk v/v littermate controls, suggesting that the qk v -associated myelination defect is not further impaired by the loss of p53. These findings indicate that qkI does not cooperate with p53 in vivo to regulate the oligodendrocyte differentiation pathway. qk v/v ; p53 2/2 mice displayed Purkinje-cell defects in the cerebellum characterized by dendritic arborization defects and cell body loss, suggesting that qkI is required for neuronal cell maintenance in the absence of p53. However, the exact mechanism by which this phenotype occurs has yet to be elucidated. Cerebellar defects have previously been documented in mice homozygous for the qk v mutation. Three month old qk v/v mice displayed axonal swellings in both the Purkinje and granular cell layer, indicative of axonal injury 40 . Axonal swelling is characteristic of inflammatory lesions in Multiple Sclerosis and experimental autoimmune encephalitis, suggesting that axonal pathology is secondary to myelination defects [48] [49] . 2/2 and qk v/1 ; p53 2/2 mice in our study succumbed to thymic lymphoma, demonstrating clear symptoms including difficulty breathing due to tumor-induced compression of the lungs, enlarged ribcages, and lethargy due to tumor burden. Necropsy of these mice revealed highly vascularized, enlarged thymuses that completely encompassed the heart and the majority of the lungs, and in some instances, extended outside the ribcage into the subcutaneous layers. These symptoms were not observed in any of the qk ; p53 2/2 mice. The qk v/v mutation results in brainspecific loss of qkI isoforms -6/7, resulting in preferential sensitization of the nervous system to tumorigenesis in the absence of p53. As mentioned earlier, our post-mortem pathological observation methods were limited, thus it is possible that qk v/v mice developed additional brain tumors that remained undetected, including medulloblastomas. Although we suspect that qkI and p53 participate in different signaling pathways since double mutant qk v/v ; p53
mice displayed a novel phenotype not observed in either parent strain, a bioinformatics analysis has identified p53 as a putative target of QKI in mice. The p53 mRNA harbors a putative QRE (QUAKING Response Element) within its 3'UTR (UACUAACnnnnGAAG) 47 . These findings indicate that QKI may regulate p53 mRNA levels in vivo. Consistent with these findings, the C. elegans homolog of QKI, GLD-1, is known to associate with the p53 cep-1 mRNA and regulate its activity 25 . In conclusion, QKI proteins are highly conserved among species and have been implicated in multiple diverse biological pathways, highlighting the pivotal role of RNA binding proteins in cellular function. Our data suggests that qkI interacts with p53 in vivo to regulate neuronal maintenance and survival.
Methods
Antibodies. Monoclonal MBP and NFH antibodies were obtained from Sternberger Monoclonals (Baltimore, MD). Monoclonal Calbindin-D-28K and GFAP antibodies were purchased from Sigma (St. Louis, MO). Anti-CD31 was purchased from Millipore (Billerica, MA). Antibodies against QKI-5,-6, and -7 were generated as described previously 7, 42 . Animals. Mice were monitored daily and were handled and sacrificed in accordance with a protocol approved by the Animal Care Committee at McGill University. The mice were housed in ventilated cages with a 12/12 hour light/dark cycle. p53 2/2 mice (lab stock # 002101) and qk v mice (lab stock # 000506) were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice colonies were maintained on a C57BL/6 background. Mice homozygous for the p53 mutation were crossbred to heterozygous qk v mice and subsequent trans-heterozygous crosses were used to generate qk v/1 ; p53 2/2 males. These males were subsequently crossbred to trans-heterozygous females to generate double mutant mice. Mice were screened for the p53 wild-type allele via genomic PCR using oligonucleotides (59-ATA GGT CGG CGG TTC AT-39) and (59-CCC GAG TAT CTG GAA GAC AG-39). The mutant p53 allele was identified using the following oligonucleotides: (59-CTT GGG TGG AGA GGC TAT TCG-39) and (59-GTC GGG CAT GCG CGC CTT GAG-39). The qk v mutation was amplified using primers directed against the breakpoint (59-TCT AAA GAG CAT TTT CGA AGT-39) and (59-TTG CTA ACT GAA TAT TAC T-39).
Immunohistochemistry. Mice were anaesthetized with isoflurane and perfused with ice-cold phosphate buffered saline followed by 4% paraformaldehyde. Brains were cryoprotected in 30% sucrose overnight and embedded in OCT compound (TissueTek, Markham, ON) over dry ice in acetone. Tissues were cryostat sectioned at a thickness of 10 mm and collected on 1/1 slides (Fisher, Ottawa, ON). Tissue sections were blocked in 10% goat serum in Tris-buffered saline 1 0.5 % Triton X-100 for 1 hr followed by incubation with primary antibodies overnight at room temperature. Slides were incubated with Alexa-flour 488 or 546 Immunoglobulin G (Invitrogen, Carlsbad, CA) at a dilution of 1:400 for 4 hr. Corpus callosum thickness was visualized by MBP staining and quantified for 4 different areas using Axiovision software (Zeiss). P14 and P30 mice cerebellar coronal sections were evaluated at bregma ,25.8 mm, and representative images were taken of the simple lobule adjacent to the primary fissure. Purkinje cell linear density was quantified for 3 different areas using Axiovision software. Purkinje cell linear density was quantified as Calbindinpositive cell bodies/mm Purkinje cell layer. Statistical significance was calculated according to a two-sample two-tailed paired student t-test.
